Ensysce Biosciences Inc. (ENSC)
NASDAQ: ENSC
· Real-Time Price · USD
2.09
-0.06 (-2.79%)
At close: Aug 14, 2025, 3:59 PM
2.09
0.00%
After-hours: Aug 14, 2025, 06:56 PM EDT
-2.79% (1D)
| Bid | 2.06 |
| Market Cap | 4.95M |
| Revenue (ttm) | 2.81M |
| Net Income (ttm) | -6.82M |
| EPS (ttm) | 110.31 |
| PE Ratio (ttm) | 0.02 |
| Forward PE | -43.2 |
| Analyst | n/a |
| Ask | 2.17 |
| Volume | 91,687 |
| Avg. Volume (20D) | 398,380 |
| Open | 2.15 |
| Previous Close | 2.15 |
| Day's Range | 2.06 - 2.16 |
| 52-Week Range | 1.62 - 14.67 |
| Beta | 1.02 |
About ENSC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENSC
Website n/a
Earnings Surprise
Ensysce Biosciences has released their quartely earnings
on Aug 13, 2025:
Next Earnings Release
Ensysce Biosciences Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+0.48%
ENSC stock has given up its prior gain. Ensysce Bi...
Unlock content with
Pro Subscription
2 weeks ago
+0.48%
Ensysce Biosciences shares are trading higher after the company announced it received FDA feedback for PF614-MPAR.
1 month ago · accessnewswire.com
Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~ ~ Grant Funds from NIDA Accelerating Clinical Development Program ~ SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 24, 2025 / En...
2 months ago · accessnewswire.com
Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025~ Pain Management, RE-Invented: A New Era for Analgesia ~ SAN DIEGO, CA / ACCESS Newswire / June 11, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharm...
